Automated description from the Alliance of Genome Resources (Release 8.3.0)
Enables G protein-coupled opioid receptor activity and mu-type opioid receptor binding activity. Predicted to be involved in several processes, including cyclooxygenase pathway; negative regulation of nitric oxide biosynthetic process; and positive regulation of protein localization to nucleolus. Located in postsynaptic density. Is active in postsynapse. Is expressed in several structures, including brain; genitourinary system; gut; hemolymphoid system gland; and liver. Human ortholog(s) of this gene implicated in alcohol dependence; amyotrophic lateral sclerosis type 16; and autosomal recessive distal hereditary motor neuronopathy 2. Orthologous to human SIGMAR1 (sigma non-opioid intracellular receptor 1).
This site uses cookies.
Some cookies are essential for site operations and others help us analyze use and utility of our web site.
Please refer to our
privacy policy
for more information.